Researchers Identified Antiviral Compounds in Bee, Spider Products
New scientific research indicates that substances from bees and spiders successfully inhibited avian coronavirus replication.
Updated on Sept. 25, 2026 in Diseases — General

Live Poll
Do you trust that natural compounds could play a significant role in future antiviral medical treatments?
Scientists have discovered that compounds derived from bees and spiders demonstrate significant antiviral effects against avian coronavirus. The findings show these biological substances can reduce viral titers and prevent new viral particles from spreading in cell cultures.
Why it matters
The urgent need for new antiviral products to combat emerging and re-emerging viral infections has driven this exploration into non-traditional biological sources. By identifying potential treatments in invertebrate-derived compounds, researchers hope to diversify the available toolkit for managing viral threats.
Researchers observed that propolis and crude hemolymph reduced avian coronavirus by an average of 256 times in infected cells. Additionally, applying treatments one hour before infection resulted in antiviral effects that were two times more intense.
The players
Scaptotrigona aff postica
This is a species of stingless bee whose propolis was tested for potential antiviral properties.
Lonomia obliqua
This is a species of silk moth whose hemolymph was analyzed for its ability to contain viral infection.
Acanthoscurria gomesiana
This is a species of spider known as the Brazilian giant tawny redleg, from which mygalin was isolated.
The details
The study evaluated the efficacy of substances including propolis from Scaptotrigona aff postica, hemolymph from Lonomia obliqua, and mygalin from Acanthoscurria gomesiana. These compounds inhibited viral replication in a dose-dependent manner, with synthetic mygalin demonstrating a 16-fold reduction in virus titer at 26 µM concentrations.
Timeline
September 25, 2026: Findings were published in a scientific report regarding invertebrate-derived antiviral research.
The Big Picture
This discovery aligns with the ongoing search for novel antimicrobial compounds in nature to combat evolving viral threats. It marks a significant expansion of the search for antiviral agents beyond traditional synthetic pharmaceuticals and into the specialized defense mechanisms of invertebrates.
While this study provides promising laboratory data, these substances are not currently available as medical treatments for human or animal use. Further investigation is required to determine the safety, efficacy, and clinical utility of these compounds before they can impact standard medical care.
The takeaway
This research underscores the potential of insect and arachnid biology to serve as a library for future pharmaceutical discovery. Identifying such compounds early in the experimental process helps researchers pinpoint specific molecular targets for developing more effective antiviral interventions.
Further reading
For broader insights into modern pathology and preventative medicine, explore the Diseases — General section.
More information
View the complete peer-reviewed research article to examine the detailed experimental results.
Source note: This article includes information reported by Nature.
Live Poll
Do you trust that natural compounds could play a significant role in future antiviral medical treatments?



